Video Latest - ecancer

Comment: Ribociclib for breast cancer

Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium

10 Oct 2016

Highlights of ESMO 2016

Dr Andrés Cervantes - ESMO 2016 Scientific Chair

10 Oct 2016

Custirsen shows no survival benefit in metastatic prostate cancer

Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France

10 Oct 2016

Benefits of adjuvant chemo for soft tissue sarcoma patients

Dr Alessandro Gronchi - National Cancer Institute, Milan, Italy

10 Oct 2016

Cabozantinib over sunitinib for metastatic renal cell carcinoma

Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA

10 Oct 2016

Negative trial results of custirsen for metastatic prostate cancer

Prof Karim Fizazi - Cancer Medicine at the Institut Gustave Roussy, Villejuif, France

10 Oct 2016

Cabozantinib improves PFS in metastatic renal cell carcinoma

Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA

10 Oct 2016

A potential prognostic biomarker of chemoresistance in mCRC treated with FUFIRI or mIrOx (FIRE1)

Dr Arndt Stahler - University of Munich, Munich, Germany

9 Oct 2016

Phase I results of a novel FGFR inhibitor

Dr Markus Joerger - Kantonsspital St. Gallen, St. Gallen, Switzerland

9 Oct 2016

Niraparib significantly improves outcomes for ovarian cancer patients

Dr Mansoor Raza Mirza - Rigshospitalet, Copenhagen University Hospital, Denmark

8 Oct 2016

Cancer care in Wales - challenges and opportunities

Prof Malcolm Mason - Cardiff University, Cardiff, UK

6 Oct 2016

What is the impact of research within communities?

Ms Alexa Bishop - Cancer Research UK, UK

6 Oct 2016

Video